--- title: "Arrowstreet Capital Limited Partnership Trims Stake in UiPath, Inc. $PATH" type: "News" locale: "en" url: "https://longbridge.com/en/news/295068643.md" description: "Arrowstreet Capital reduced its UiPath stake by 95% in Q1, while other institutions like DNB Asset Management and First Trust increased holdings. UiPath reported Q1 EPS of $0.15, meeting estimates, with revenue up 17.3% YoY. Analyst ratings remain mixed, averaging 'Hold' with a $13.80 price target, as UBS, Wall Street Zen, BMO, and DA Davidson adjusted targets or ratings recently." datetime: "2026-08-06T07:12:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295068643.md) - [en](https://longbridge.com/en/news/295068643.md) - [zh-HK](https://longbridge.com/zh-HK/news/295068643.md) generator: "portal-rs" --- # Arrowstreet Capital Limited Partnership Trims Stake in UiPath, Inc. $PATH Arrowstreet Capital Limited Partnership reduced its holdings in UiPath, Inc. (NYSE:PATH - Free Report) by 95.0% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 166,052 shares of the company's stock after selling 3,174,788 shares during the quarter. Arrowstreet Capital Limited Partnership's holdings in UiPath were worth $1,843,000 at the end of the most recent reporting period. - UiPath Fell on Good News—That Could Be the Opportunity Other institutional investors and hedge funds have also recently modified their holdings of the company. DNB Asset Management AS raised its holdings in UiPath by 266.4% in the fourth quarter. DNB Asset Management AS now owns 565,799 shares of the company's stock worth $9,273,000 after purchasing an additional 411,395 shares in the last quarter. First Trust Advisors LP boosted its holdings in shares of UiPath by 48.7% during the 1st quarter. First Trust Advisors LP now owns 1,624,148 shares of the company's stock valued at $18,028,000 after buying an additional 532,157 shares in the last quarter. State of Michigan Retirement System purchased a new stake in shares of UiPath in the 1st quarter worth about $1,143,000. Burney Co. purchased a new stake in shares of UiPath in the 4th quarter worth about $2,285,000. Finally, Vanguard Group Inc. increased its stake in shares of UiPath by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 49,114,941 shares of the company's stock worth $804,994,000 after acquiring an additional 1,219,057 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock. ## UiPath Stock Down 1.9% NYSE PATH opened at $13.84 on Thursday. The company has a 50-day moving average price of $11.47 and a 200-day moving average price of $11.43. UiPath, Inc. has a 52 week low of $9.20 and a 52 week high of $19.84. The firm has a market capitalization of $7.17 billion, a P/E ratio of 23.06, a PEG ratio of 1.69 and a beta of 0.96. - 5 AI Stocks Positioned to Win, No Matter What UiPath (NYSE:PATH - Get Free Report) last announced its earnings results on Thursday, May 28th. The company reported $0.15 EPS for the quarter, meeting analysts' consensus estimates of $0.15. UiPath had a net margin of 19.58% and a return on equity of 7.92%. The business had revenue of $418.38 million during the quarter, compared to analysts' expectations of $397.54 million. During the same period in the prior year, the company earned $0.11 earnings per share. The firm's revenue was up 17.3% on a year-over-year basis. As a group, equities research analysts anticipate that UiPath, Inc. will post 0.4 EPS for the current year. ## Wall Street Analyst Weigh In PATH has been the topic of several research reports. UBS Group dropped their price objective on shares of UiPath from $13.00 to $12.00 and set a "neutral" rating on the stock in a research note on Monday, June 29th. Wall Street Zen lowered shares of UiPath from a "buy" rating to a "hold" rating in a report on Saturday, May 30th. BMO Capital Markets dropped their price target on UiPath from $14.00 to $13.00 and set a "market perform" rating on the stock in a research report on Monday, June 1st. Needham & Company LLC restated a "buy" rating and issued a $15.00 price target on shares of UiPath in a research note on Friday, May 29th. Finally, DA Davidson reduced their price objective on UiPath from $13.00 to $12.00 and set a "neutral" rating for the company in a research report on Friday, May 29th. Two analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $13.80. - The Next Market Leaders? 5 Growth Stocks to Watch in 2026 **View Our Latest Research Report on PATH** ## UiPath Profile (Free Report) UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. ## Featured Stories - Five stocks we like better than UiPath - SpaceX: Love the Company, But the Stock Is a Harder Call - Ulta's Growth Is Real, But So Are the Risks - BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story - Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth **Want to see what other hedge funds are holding PATH?** Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH - Free Report). *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in UiPath Right Now? Before you consider UiPath, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list. While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [PATH.US](https://longbridge.com/en/quote/PATH.US.md) - [PATX.US](https://longbridge.com/en/quote/PATX.US.md) - [UBS.US](https://longbridge.com/en/quote/UBS.US.md) - [BMO.US](https://longbridge.com/en/quote/BMO.US.md) ## Related News & Research - [UiPath Just Delivered 2 Bullish Signals and 1 Warning Sign for Investors](https://longbridge.com/en/news/288760190.md) - [UiPath to Participate in the William Blair 46th Annual Growth Stock Conference | PATH Stock News](https://longbridge.com/en/news/287674605.md) - [QumulusAI Anchors Metro Atlanta Data Center Site With a Contracted 3.75 MW and a Path to 10.75 MW | QMLS Stock News](https://longbridge.com/en/news/296486952.md) - [UiPath Stock Just Fell by 15%. Here's Why This Could Be a Great Buying Opportunity.](https://longbridge.com/en/news/293714067.md) - [Inovalon, UST, and AXIOM Systems Join 1upHealth's Partner Program](https://longbridge.com/en/news/296497529.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**